Benign Prostatic Hyperplasia

Discover unique market-leading data and insights into the Benign Prostatic Hyperplasia market. From the latest Benign Prostatic Hyperplasia industry reports and analysis to comprehensive market growth forecasts, trends and research.

Browse our full list of Benign Prostatic Hyperplasiamarket reports here.

1 - 1 of 1 reports

Currency USD

Sort by Relevance

View List

Results per page

Product Insights

$2,000 | June 2024

Benign Prostatic Hyperplasia - Drugs In Development, 2024

$2,000 | June 2024

Empower your strategies with our Benign Prostatic Hyperplasia – Drugs In Development, 2024 report and make more profitable business decisions. Benign prostatic hyperplasia (BPH) is a non-cancerous enlargement of the prostate, a small gland that encircles the urethra in males and produces a fluid that makes up part of semen. Symptoms include decreased strength of the urine stream, dribbling after urination, pain during urination, waking at night to urinate, and difficulty starting a urine stream. Treatment options for BPH include surgery...

Add to Wishlist

Saved to Wishlist | Remove

Saved to Wishlist | Remove

1 - 1 of 1 reports

Results per page

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.

Reports

Reports by Sector

Report Type

Benign Prostatic Hyperplasia

Refine by:

Product Insights